Alzheimer's Disease

Primary cultures offer fast access to study molecules of interest directly in relevant cell types. Primary cultures are real cells present in tissue instead of immortalized cell lines and are good tools for lead molecule identification (efficacy and toxicity screening).

Charles River conducts contract studies in an established in vitro model of Alzheimer’s disease to assess the efficacy of novel compounds. In Alzheimer’s disease, the cortex and hippocampus are the most affected brain areas that are seriously damaged by amyloid beta (Aβ). These target cells can be cultured and exposed to the toxic form, Aβ1-42. Cell death is determined by LDH release and immunocytochemical evaluation of viable cells. Data is available within few weeks from study initiation.

Testing / Validation Data

Click below to see a sample data set.

You may also be interested in...

In Vivo Alzheimer's Disease Model

Charles River's Alzheimer's disease platform includes transgenic CVN and Tg2576 mice, which display pathologies associated with Alzheimer's disease.

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.